Riot Platforms, Inc. — Director's Dealing 2012

Jul 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-06-29

Reporting Person: Merson Michael R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-29	Common Stock	P	1000	$1.92	Acquired	1180	Direct

Footnotes

F1: Reflects a one-for-five reverse stock split effected July 29, 2011, and a one-for-six reverse stock split effected June 20, 2012.